Andrew E. (Division Deputy Director, Gastroenterology and Inborn Error Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA) Mulberg
Meer over de auteurs
Andrew E. (Division Deputy Director, Gastroenterology and Inborn Error Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA) Mulberg,
Dianne (Director, Office of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA) Murphy,
Julia (Vigilance and Risk Management in Medicines (VRMM), Medicines and Healthcare Products Regulatory Agency, London, UK) Dunne,
Lisa L. (Executive Director for Global Regulatory Affairs and Safety (GRAAS), Amgen Incorporated, Thousand Oaks, CA, USA) Mathis
e.a.
John Wiley and Sons Ltd
e druk, 2013
9781118312155
Pediatric Drug Development
Specificaties
Gebonden, 624 blz.
|
EN
John Wiley and Sons Ltd |
2013
ISBN13: 9781118312155
Rubricering
Levertijd ongeveer 16 werkdagen
Gratis verzonden
Samenvatting
Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.
Specificaties
ISBN13:9781118312155
Taal:EN
Bindwijze:Gebonden
Aantal pagina's:624
Uitgever:John Wiley and Sons Ltd